Integrin Beta1 Market, By Type (AXT-108, C-16Y, CLT-28643, SAL-021 and Others), By Indication (Genetic Disorder, Dermatology, Cardiovascular and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI467721 | Publish Date: August 2023 | No. of Pages: 168

Market Companies

  • Avipero Ltd
  • Clanotech AB
  • Morphic Therapeutic Inc
  • Strykagen Corp
  • Valeant Pharmaceuticals International Inc.

Recent News:

  • According to Elsevier B.V. article, significant molecular evidence supports beta1 integrin's significance in tissue organization and remodelling, which is essential for cell proliferation, differentiation, migration, and survival. The transgenic method has been used to highlight this role, but it offers little to clarify the more nuanced roles, such those governed by avidity regulation. It is well known that integrins, especially beta1 integrin, display global structural rearrangement and ligand binding site exposure upon activation. The regulation of beta1 integrin has been linked to tissue regeneration and repair, according to recent research.